Versus Arthritis is seeking applications to support high-quality, well-defined proof of concept projects aimed at developing commercially viable technologies to address unmet clinical needs for people with arthritis.
Category
Grant
Program Overview
Versus Arthritis' research strategy aims to accelerate the pace and precision of musculoskeletal research. They seek to fund research that addresses the needs of people with arthritis and has the potential to significantly improve their quality of life. This translational funding scheme supports projects that bridge the gap from early-stage research to commercial development, advancing novel technologies towards clinical use.
Scope
The initiative seeks to fund projects in the following technology areas:
- Medical Devices: Instruments, apparatus, implants, or software intended for medical purposes.
- Orthotics: External devices like braces or splints for supporting, immobilizing, or treating skeletal parts.
- Implantable Therapeutic Delivery: Devices or systems to control the release of therapeutic agents to improve efficacy and safety.
- Diagnostics: In vitro diagnostic tests used to detect diseases or determine health status.
- Imaging Technologies: Methods and processes for imaging the human body for diagnosis, monitoring, and treatment.
- Cell Therapy and Regenerative Medicine: Methods to replace or regenerate human cells, tissues, or organs, including cell therapies and tissue engineering.
- Novel Therapeutics (Small Molecules or Biologics): Proposals focusing on core Proof of Concept experiments for novel therapeutics.
What They Are Looking For
The funding should advance technologies along the developmental pathway leading to further investment and/or development by industry. Projects should be developed to a stage where further validation is required to attract commercial investment.
Funding Information
Grants of up to £200,000 are available for a duration of up to 24 months for successful applicants who demonstrate a clear commercial solution to a musculoskeletal clinical need.
Eligibility Criteria
- Applications must be held at universities, hospitals, or recognized academic research institutes in the UK.
- Academic, clinician, or allied health care professionals at eligible UK institutions can apply.
- The lead applicant must be based at an eligible UK institution. Individuals employed by commercial organizations are not eligible to apply but may be included as co-applicants.
- At least one applicant must have a tenured position within the lead institute.
- Applications with industrial partners are encouraged. Proposals with part-funding from third parties are allowable but should be discussed with Versus Arthritis early.
- International collaborators and individuals with lived experience may also be included as co-applicants.
- Previous holders of MedTech awards from Versus Arthritis can apply if their project fits the scope of this call.
.jpg)
.jpg)
.jpeg)
.jpg)
.jpg)
.jpg)
0 Comments